{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T05:40:00Z","timestamp":1774158000605,"version":"3.50.1"},"reference-count":31,"publisher":"Scientific Scholar","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,2]]},"abstract":"Abstract<\/jats:title>\n \n Background & objectives:<\/jats:title>\n There is limited evidence studying the relationship of liver segmental dose and segmental volume changes. The segmental dose thresholds could potentially allow for segmental regeneration after liver stereotactic body radiation therapy (SBRT). Given improved survival in hepatocellular cancer (HCC) and liver metastases and more salvage therapy options, this has become an important clinical question to explore. This study assesses the impact of liver segmental dose on segmental volume changes (gain or loss) after SBRT.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Liver segmental contours were delineated on baseline and serial follow up triphasic computed tomography scans. The volumes of total liver and doses to total liver, uninvolved liver and individual segments were noted. A correlation was evaluated between liver\/segmental volume and dose using Pearson\u2019s correlation. Furthermore, receiver operator\u2019s curve (ROC) analysis was performed to find the segmental dose, i.e<\/jats:italic>. predictive for liver volume loss.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n A total of 140 non-tumour liver segments were available for analysis in 21 participants. Overall, 13 participants showed loss of overall liver volume and eight showed gain of overall liver volume. The median dose in segments reporting an increase in volume was 9.1 Gy (7-36 Gy). The median dose in segments losing volume was 15.5 Gy (1-49 Gy). On ROC analysis, segmental dose >11 Gy was associated with volume loss. On univariate analysis, only liver segmental dose contributed to a significant segmental volume loss.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n We propose from the findings of this study that in SBRT for large hepatocellular cancer or liver metastases, liver segments should be individually delineated. Furthermore, 3-5 liver segments may be preferentially subjected to <9 Gy to facilitate hepatocyte regeneration. Preferential sparing of uninvolved liver segments may improve outcomes in liver stereotaxyas lower segmental doses were associated with liver regeneration. This may have implications on future liver SBRT planning where segmental doses may be as important as the mean dose.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1171_21","type":"journal-article","created":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T09:32:19Z","timestamp":1712655139000},"page":"232-240","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of liver segmental dose threshold for hepatocyte regeneration following liver stereotactic body radiation therapy"],"prefix":"10.25259","volume":"159","author":[{"given":"Karishma","family":"George","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Supriya","family":"Chopra","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karthick","family":"Rajamanickam","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishore","family":"Joshi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamema","family":"Swamidas","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Homi Bhabha National Institute, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Shetty","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reena","family":"Engineer","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Tata Memorial Hospital, Tata Memorial Centre, Mumbai, Maharashtra, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2024,4,4]]},"reference":[{"key":"R1-20241212","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the Global Burden of Disease Study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"R2-20241212","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.jceh.2014.05.013","article-title":"Epidemiology of hepatocellular carcinoma in India","volume":"4","author":"Acharya","year":"2014","journal-title":"J Clin Exp Hepatol"},{"key":"R3-20241212","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/qjmed\/hcn033","article-title":"Characteristics of hepatocellular carcinoma in India: A retrospective analysis of 191 cases","volume":"101","author":"Kumar","year":"2008","journal-title":"QJM"},{"key":"R4-20241212","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/cncr.28730","article-title":"The clinical management of hepatocellular carcinoma in the United States, Europe, and Asia: A comprehensive and evidence-based comparison and review","volume":"120","author":"Fong","year":"2014","journal-title":"Cancer"},{"key":"R5-20241212","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s12664-014-0490-y","article-title":"Preresection transarterial chemoembolization for hepatocellular carcinoma: An experience with 23 patients","volume":"33","author":"Goel","year":"2014","journal-title":"Indian J Gastroenterol"},{"key":"R6-20241212","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1007\/s00432-015-1929-y","article-title":"The challenge of inoperable hepatocellular carcinoma (HCC): Results of a single-institutional experience on stereotactic body radiation therapy (SBRT)","volume":"141","author":"Scorsetti","year":"2015","journal-title":"J Cancer Res Clin Oncol"},{"key":"R7-20241212","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/cncr.27533","article-title":"Stereotactic body radiation therapy for inoperable hepatocellular carcinoma as a local salvage treatment after incomplete transarterial chemoembolization","volume":"118","author":"Kang","year":"2012","journal-title":"Cancer"},{"key":"R8-20241212","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ijrobp.2017.01.221","article-title":"Predictors of liver toxicity following stereotactic body radiation therapy for hepatocellular carcinoma","volume":"97","author":"Velec","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R9-20241212","article-title":"Rtog 1112. Randomized phase III study of Sorafenib versus stereotactic body radiation therapy followed by Sorafenib in hepatocellular carcinoma"},{"key":"R10-20241212","doi-asserted-by":"crossref","first-page":"20181053","DOI":"10.1259\/bjr.20181053","article-title":"Stereotactic body radio therapy for inoperable large hepatocellular cancers: Results from a clinical audit","volume":"92","author":"Chopra","year":"2019","journal-title":"Br J Radiol"},{"key":"R11-20241212","doi-asserted-by":"crossref","first-page":"e443","DOI":"10.1016\/j.prro.2015.02.007","article-title":"Treatment variables related to liver toxicity in patients with hepatocellular carcinoma, Child-Pugh class A and B enrolled in a phase 1-2 trial of stereotactic body radiation therapy","volume":"5","author":"Lasley","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"R12-20241212","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R13-20241212","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R14-20241212","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.prro.2014.09.007","article-title":"Effect of high-dose stereotactic body radiation therapy on liver function in the treatment of primary and metastatic liver malignancies using the Child-Pugh score classification system","volume":"5","author":"Dyk","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"R15-20241212","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.ijrobp.2009.09.009","article-title":"Stereotactic body radiotherapy for patients with unresectable primary hepatocellular carcinoma: Dose-volumetric parameters predicting the hepatic complication","volume":"78","author":"Son","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R16-20241212","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1200\/JCO.2007.14.3529","article-title":"Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"26","author":"Tse","year":"2008","journal-title":"J Clin Oncol"},{"key":"R17-20241212","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.ijrobp.2005.01.002","article-title":"A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases","volume":"62","author":"Schefter","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R18-20241212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-8-249","article-title":"Radiation-induced liver disease after stereotactic body radiotherapy for small hepatocellular carcinoma: Clinical and dose-volumetric parameters","volume":"8","author":"Jung","year":"2013","journal-title":"Radiat Oncol"},{"key":"R19-20241212","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1017\/CBO9780511984785.022","article-title":"Fundamentals of Hepatobiliary and Pancreatic Surgery","author":"Duxbury","year":"2011","journal-title":"Fundamentals of Surgical Practice"},{"key":"R20-20241212","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1748-717X-8-24","article-title":"Image-based response assessment of liver metastases following stereotactic body radiotherapy with respiratory tracking","volume":"8","author":"Jarraya","year":"2013","journal-title":"Radiat Oncol"},{"key":"R21-20241212","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1200\/JCO.2008.20.0600","article-title":"Phase I study of individualized stereotactic body radiotherapy of liver metastases","volume":"27","author":"Lee","year":"2009","journal-title":"J Clin Oncol"},{"key":"R22-20241212","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.ijrobp.2013.10.045","article-title":"Threshold doses for focal liver reaction after stereotactic ablative body radiation therapy for small hepatocellular carcinoma depend on liver function: Evaluation on magnetic resonance imaging with Gd-EOB-DTPA","volume":"88","author":"Sanuki","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R23-20241212","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/jrr\/rrw008","article-title":"Threshold doses and prediction of visually apparent liver dysfunction after stereotactic body radiation therapy in cirrhotic and normal livers using magnetic resonance imaging","volume":"57","author":"Doi","year":"2016","journal-title":"J Radiat Res"},{"key":"R24-20241212","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/j.jvir.2014.06.026","article-title":"Irreversible electroporation ablation of malignant hepatic tumors: Subacute and follow-up CT appearance of ablation zones","volume":"25","author":"Dollinger","year":"2014","journal-title":"J Vasc Interv Radiol"},{"key":"R25-20241212","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/j.ijrobp.2008.07.032","article-title":"Microscopic and macroscopic tumor and parenchymal effects of liver stereotactic body radiotherapy","volume":"73","author":"Olsen","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-20241212","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1259\/bjr\/74105551","article-title":"CT evaluations of focal liver reactions following stereotactic body radiotherapy for small hepatocellular carcinoma with cirrhosis: Relationship between imaging appearance and baseline liver function","volume":"83","author":"Sanuki-Fujimoto","year":"2010","journal-title":"Br J Radiol"},{"key":"R27-20241212","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.ijrobp.2010.12.047","article-title":"Image-guided robotic stereotactic body radiation therapy for liver metastases: Is there a dose response relationship?","volume":"81","author":"Vautravers-Dewas","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R28-20241212","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3857\/roj.2012.30.4.189","article-title":"Changes of the liver volume and the Child-Pugh score after high dose hypofractionated radiotherapy in patients with small hepatocellular carcinoma","volume":"30","author":"Kim","year":"2012","journal-title":"Radiat Oncol J"},{"key":"R29-20241212","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/j.ijrobp.2012.04.041","article-title":"Normal liver tissue density dose response in patients treated with stereotactic body radiation therapy for liver metastases","volume":"84","author":"Howells","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R30-20241212","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Articles Efficacy and safety of sorafenib in patients in the Asia-Pacifi c region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"key":"R31-20241212","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ijrobp.2015.12.015","article-title":"Changes in liver volume observed following sorafenib and liver radiation therapy","volume":"94","author":"Swaminath","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_1171_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T13:52:16Z","timestamp":1751464336000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.4103\/ijmr.ijmr_1171_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1171_21","relation":{},"ISSN":["0971-5916","0975-9174"],"issn-type":[{"value":"0971-5916","type":"print"},{"value":"0975-9174","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"2021-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}}]}}